Why Lyme?

Why Lyme?

has turned into a 1.3b dollar problem

Woods


 

By David Addona

September 6, 2019

 

Each year there are reportedly 329,000 new Lyme disease cases in the U.S. That’s more than the total cases of breast cancer yet it receives .03% of its funding. While the infectious disease community has yet to develop what you’d consider a handle on the disease, other conditions comparably misunderstood, don’t receive the same pushback in terms of legitimacy.

Novel research, most of which has been funded privately has come to find Neurological disorders like ALS, Parkinson’s and Bell’s palsy have demonstrable links to Lyme. Within the past decade, The International Journal of Infectious Disease performed case studies in which Lyme disease patients have developed what’s called Lyme Cranial Nerve Palsy while being treated with routine Doxycycline. In other words, Borrelia burgdorferi has become much more elaborate in finding ways to survive in the human body. At the same time, it’s collaboratively fortifying its adaptogenic ability to go undetected.

Continue reading “Why Lyme?”